FI3774844T3 - Elamipretidin synteesissä hyödyllisiä kiteisiä dipeptidejä - Google Patents

Elamipretidin synteesissä hyödyllisiä kiteisiä dipeptidejä Download PDF

Info

Publication number
FI3774844T3
FI3774844T3 FIEP19781432.0T FI19781432T FI3774844T3 FI 3774844 T3 FI3774844 T3 FI 3774844T3 FI 19781432 T FI19781432 T FI 19781432T FI 3774844 T3 FI3774844 T3 FI 3774844T3
Authority
FI
Finland
Prior art keywords
crystalline form
xrpd pattern
characteristic peaks
theta values
crystalline
Prior art date
Application number
FIEP19781432.0T
Other languages
English (en)
Finnish (fi)
Inventor
Scott Duncan
Martin Redmon
Original Assignee
Stealth Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Inc filed Critical Stealth Biotherapeutics Inc
Application granted granted Critical
Publication of FI3774844T3 publication Critical patent/FI3774844T3/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FIEP19781432.0T 2018-04-02 2019-03-28 Elamipretidin synteesissä hyödyllisiä kiteisiä dipeptidejä FI3774844T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862651430P 2018-04-02 2018-04-02
PCT/US2019/024617 WO2019195080A1 (en) 2018-04-02 2019-03-28 Crystalline dipeptides useful in the synthesis of elamipretide

Publications (1)

Publication Number Publication Date
FI3774844T3 true FI3774844T3 (fi) 2023-04-04

Family

ID=68101313

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP19781432.0T FI3774844T3 (fi) 2018-04-02 2019-03-28 Elamipretidin synteesissä hyödyllisiä kiteisiä dipeptidejä

Country Status (13)

Country Link
US (4) US10975118B2 (https=)
EP (2) EP4219523A3 (https=)
JP (2) JP7350007B2 (https=)
KR (2) KR20250010134A (https=)
CN (2) CN112292388B (https=)
AU (1) AU2019249121B2 (https=)
CA (2) CA3280578A1 (https=)
DK (1) DK3774844T3 (https=)
ES (1) ES2941266T3 (https=)
FI (1) FI3774844T3 (https=)
IL (2) IL277718B2 (https=)
PT (1) PT3774844T (https=)
WO (1) WO2019195080A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3017359A1 (en) * 2016-03-11 2017-09-14 Scott M. Duncan Crystalline salt forms
KR20250010134A (ko) 2018-04-02 2025-01-20 스텔스 바이오테라퓨틱스 인코포레이티드 엘라미프레티드의 합성에 유용한 결정질 디펩티드
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4711166B2 (ja) * 2004-08-03 2011-06-29 株式会社 液晶先端技術開発センター 結晶化装置、および結晶化方法
CA3022250A1 (en) * 2012-12-12 2014-06-12 Ariad Pharmaceuticals, Inc. Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
CN108558969A (zh) * 2014-03-28 2018-09-21 江苏天士力帝益药业有限公司 吡唑衍生物的多晶型物
WO2016001042A1 (en) 2014-06-30 2016-01-07 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
EP3265109B1 (en) * 2015-03-06 2020-10-21 Stealth BioTherapeutics Corp Processes for preparing pharmaceutically relevant peptides
AU2016272089B2 (en) * 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
CA3017359A1 (en) * 2016-03-11 2017-09-14 Scott M. Duncan Crystalline salt forms
EP3500286A4 (en) 2016-08-16 2020-03-25 Stealth BioTherapeutics Corp N-CARBOXYANHYDRIDE-BASED SCALE SYNTHESIS OF ELAMIPRETID
US11034724B2 (en) * 2017-04-05 2021-06-15 Stealth Biotherapeutics Corp. Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2
KR20250010134A (ko) 2018-04-02 2025-01-20 스텔스 바이오테라퓨틱스 인코포레이티드 엘라미프레티드의 합성에 유용한 결정질 디펩티드

Also Published As

Publication number Publication date
AU2019249121B2 (en) 2024-05-02
CA3280578A1 (en) 2025-10-30
JP2021520357A (ja) 2021-08-19
US20200283476A1 (en) 2020-09-10
US12018094B2 (en) 2024-06-25
CN112292388B (zh) 2024-04-19
JP2023165756A (ja) 2023-11-17
PT3774844T (pt) 2023-03-28
JP7350007B2 (ja) 2023-09-25
US20250122238A1 (en) 2025-04-17
CN112292388A (zh) 2021-01-29
JP7663642B2 (ja) 2025-04-16
IL277718B2 (en) 2025-02-01
IL315355A (en) 2024-11-01
KR102753323B1 (ko) 2025-01-09
ES2941266T3 (es) 2023-05-19
AU2019249121A1 (en) 2020-11-26
EP4219523A3 (en) 2023-08-09
CA3095869A1 (en) 2019-10-10
IL277718B1 (en) 2024-10-01
IL277718A (en) 2020-11-30
CN118206614A (zh) 2024-06-18
US11560404B2 (en) 2023-01-24
KR20210005042A (ko) 2021-01-13
CA3095869C (en) 2025-10-21
EP3774844B1 (en) 2023-02-22
EP3774844A4 (en) 2021-12-15
US10975118B2 (en) 2021-04-13
EP3774844A1 (en) 2021-02-17
EP4219523A2 (en) 2023-08-02
US20230203093A1 (en) 2023-06-29
WO2019195080A1 (en) 2019-10-10
US20210292274A1 (en) 2021-09-23
DK3774844T3 (da) 2023-04-03
KR20250010134A (ko) 2025-01-20

Similar Documents

Publication Publication Date Title
FI3774844T3 (fi) Elamipretidin synteesissä hyödyllisiä kiteisiä dipeptidejä
EP4345084A3 (en) Use of type of compounds as energetic material
EA201792152A1 (ru) Антенная панель транспортного средства
AR105389A1 (es) Compuestos basados en ferroceno y catalizadores de paladio basados en los mismos para la alcoxicarbonilación de compuestos etilénicamente instaurados
WO2016105165A3 (ko) 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자
WO2017059059A8 (en) Crystalline forms of a hepatitis b antiviral agent
AR112276A1 (es) Polimorfos de 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona
EA201591497A1 (ru) Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина
WO2015169270A3 (en) Light source
MX390421B (es) Proceso para preparar 4-amino-piridazinas.
WO2016105161A3 (ko) 유기 화합물 및 이를 포함하는 유기 전계 발광 소자
MX2018000881A (es) Articulos pirorretardantes de poliolefina.
EA201600403A1 (ru) N-ацилиминогетероциклические соединения
WO2016069321A3 (en) Electroactive materials
WO2020259724A3 (zh) 一种吡唑酮并嘧啶类化合物、其制备方法及应用
MY199339A (en) Additive mixture
CL2018002094A1 (es) Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediario
TR201909749T4 (tr) Kasa tipi paketin üretimine yönelik makine.
CO2022000748A2 (es) Compuesto de pirazolopirimidina, método de preparación para el mismo y sus aplicaciones
SG11201809243YA (en) Condensed heterocyclic compound
TW201612187A (en) Organic electroluminescent materials and devices
WO2009112954A3 (en) Processes for the preparation of bosentan and related compounds
CO2018008253A2 (es) Proceso para preparar compuestos de 7h-pirrolo[2,3-d]pirimidina
WO2015027137A8 (en) Improved synthesis of capuramycin and its analogues
WO2009030450A3 (en) Novel herbicides